Pricing

Log inSign up

HemoShear Therapeutics

37 people · 0 jobs
‌

HemoShear Therapeutics develops new treatments for patients with rare metabolic disorders.

Industries

Biotechnology, Health Care

Headquarters

Charlottesville, United States

Employees

11-50

Links

Org chart

Brian Wamhoff
Interim CEO
Collapse
Aric Holsinger
CFO
Patrick Horn
CMO
Michael Innes
CBO
Mark Hayes
Acting Chief Regulatory Officer
Mavis Waller
VP, Clinical Operations
Jeffrey Qureshi
VP, Legal Affairs
Mike Simmers
VP, Operations
Paul Sartori
AVP, Organizational Development & Human Resources
MC
M. Sol Collado
Executive Director, Head Of Discovery Biology
Ryan Feaver
Executive Director, Head Of Exploratory Biology

Board & advisors

Robert J. Gould
Chairman
John L. Brooks III
Board Member
John Tilton
Board Member
H. Thomas Watkins III
Board Member
Kathleen M. Metters
Board Member
GC
Gerald Cox
Advisor
MA
Moeen Al-Sayed
Advisor
JR
John E. Reardon
Advisor
AS
Arun Sanyal
Advisor
KC
Kimberly Chapman
Advisor
GE
Gregory Enns
Advisor
JV
Jerry Vockley
Advisor
NL
Nicola Longo
Advisor
MB
Mattias Baumgartner
Advisor
TR
Tom Roper
Advisor

Teams

JV
KC
+11

Advisory and Governance

15 people · 0 jobs

+4

Leadership Team

8 people · 0 jobs

+3

Research and Development

7 people · 0 jobs

GL

Clinical Operations

3 people · 0 jobs

Offices

Similar companies

Tango Therapeutics

3 followers

Merck

282 followers

Cellares

4 followers

Function Health

12 followers

Revvity

9 followers

Gilead Sciences

159 followers

Regeneron

130 followers

AtriCure

4 followers

Illumina

79 followers

Agilent Technologies

81 followers

Apollo Global Management

46 followers

Explore companies